Hostname: page-component-586b7cd67f-g8jcs Total loading time: 0 Render date: 2024-12-01T02:14:58.318Z Has data issue: false hasContentIssue false
  • English
  • Français

Macrolide and Clindamycin Resistance in Staphylococcus aureus Isolates and Antibiotic Use in a Veterans Affairs Medical Center

Published online by Cambridge University Press:  02 January 2015

Rohit Modak ,
David Ross  and
Virginia L. Kan
Rohit Modak
Affiliation:
Infectious Diseases Section, Medical Service, Veterans Affairs Medical Center, Washington, DC
David Ross
Affiliation:
Infectious Diseases Section, Medical Service, Veterans Affairs Medical Center, Washington, DC
Virginia L. Kan*
Affiliation:
Infectious Diseases Section, Medical Service, Veterans Affairs Medical Center, Washington, DC
*
Infectious Diseases Section, VA Medical Center (151B), 50 Irving St. N.W., Washington, DC 20422 ([email protected])
Get access Rights & Permissions [Opens in a new window]

Abstract

A retrospective analysis of 13,946 Staphylococcus aureus isolates revealed a stable incidence of isolates that were resistant to both clindamycin and erythromycin, but a significantly increasing incidence of isolates that were susceptible to clindamycin and resistant to erythromycin during 1991-1995, 1996-2000, and 2001-2005. The use of macrolides and clindamycin also increased during 1996-2005. The incidence of S. aureus isolates with inducible clindamycin resistance increased steadily and significantly during the period from August 2004 through December 2005.

Type
Concise Communications
Information
Infection Control & Hospital Epidemiology , Volume 29 , Issue 2 , February 2008 , pp. 180 - 182
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Herold, BC, Immergluck, LC, Maranan, MC, et al.Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 1998;279:593–598.CrossRefGoogle ScholarPubMed
2.Marcinak, JF, Frank, JL. Treatment of community-acquired methicillin-resistant Staphylococcus aureus in children. Curr Opin Infect Dis 2003;16:265–269.CrossRefGoogle ScholarPubMed
3.McGehee, RF, Barrett, FF, Finland, F. Resistance of Staphylococcus aureus to lincomycin, clindamycin, and erythromycin. Antimicrob Agents Chemother (Bethesda) 1968;13:392–397.Google Scholar
4.Fiebelkorn, KR, Crawford, SA, McElmeel, ML, Jorgensen, JH. Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci. J Clin Microbiol 2003;41:4740–4744.CrossRefGoogle ScholarPubMed
5.Patel, M, Waites, KB, Moser, SA, Cloud, GA, Hoesley, CJ. Prevalence of inducible clindamycin resistance among community- and hospital-associated Staphylococcus aureus isolates. J Clin Microbiol 2006;44:2481–2484.CrossRefGoogle ScholarPubMed
6.Shlaes, DM, Gerding, DN, John, JF, et al.Society for Healthcare Epidemiology of American and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention and treatment of antimicrobial resistance in hospitals. Clin Infect Dis 1997;25:584–599.CrossRefGoogle Scholar
7.Hindler, J. Appendix (to routine disk diffusion test) clindamycin disk induction test for Staphylococcus spp. In: National Committee for Clinical Laboratory Standards (NCCLS). Performance Standards for Antimicrobial Susceptibility Testing: 14th Informational Supplement. Wayne, PA: NCCLS; 2004: M100-S14.Google Scholar
8.Azap, OK, Arslan, H, Timurkaynak, F, Yapar, G, Oruc, E, Gagir, U. Incidence of inducible clindamycin resistance in staphylococci: first results from Turkey. Clin Microbiol Infect 2005;11:582–584.CrossRefGoogle ScholarPubMed
9.Van Horn, KG, Toth, C. Inducible clindamycin resistance in staphylococci in a tertiary care institution. In: Program and abstracts of the 103rd General Meeting of the American Society for Microbiology (Washington, DC). 2003:75. Abstract C-074.Google Scholar
10.Schreckenberger, PC, Ilendo, E, Ristow, KL. Incidence of constitutive and inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci in a community and tertiary care hospital. J Clin Microbiol 2004;42:2777–2779.CrossRefGoogle Scholar